| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 179.846.220 $ | +39.780.652 $ | +31,3 % | 14 | 125.413.752 $ | +125.413.752 $ | 11 | |||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 31.871.032 $ | +9.602.956 $ | +43,1 % | 1 | 22.268.076 $ | +22.268.076 $ | 1 | ||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 24.201.843 $ | +4.146.920 $ | +20,7 % | 1 | 20.054.923 $ | +20.054.923 $ | 1 | |
| Shattuck Labs, Inc. | STTK | → 0 | Schwach | 20.253.902 $ | +8.756.741 $ | +76,2 % | 1 | 11.497.161 $ | +11.497.161 $ | 1 | |
| Vor Biopharma Inc. | VOR | → 0 | Neutral | 17.839.411 $ | +4.759.843 $ | +36,4 % | 1 | 13.079.568 $ | +13.079.568 $ | 1 | |
| Zenas BioPharma, Inc. | ZBIO | → 0 | Schwach | 8.342.689 $ | -3.348.514 $ | -28,6 % | 1 | 11.691.203 $ | +11.691.203 $ | 1 | |
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 11.178.381 $ | +5.985.227 $ | +115,3 % | 1 | ||||
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Neutral | 10.965.004 $ | +3.730.599 $ | +51,6 % | 1 | 7.234.405 $ | +7.234.405 $ | 1 | |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 10.654.534 $ | +2.420.921 $ | +29,4 % | 1 | 8.233.613 $ | +8.233.613 $ | 1 | |
| PALVELLA THERAPEUTICS, INC. | PVLA | → 0 | Schwach | 10.306.810 $ | +1.652.066 $ | +19,1 % | 1 | 8.654.744 $ | +8.654.744 $ | 1 | |
| Verastem, Inc. | VSTM | → 0 | Neutral | 6.926.040 $ | -3.166.548 $ | -31,4 % | 1 | 10.092.588 $ | +10.092.588 $ | 1 | |
| Inventiva S.A. | IVA | → 0 | Schwach | 7.400.836 $ | +1.361.876 $ | +22,6 % | 1 | 6.038.960 $ | +6.038.960 $ | 1 | |
| CRESCENT BIOPHARMA, INC. | CBIO | → 0 | Neutral | 6.849.365 $ | +2.427.293 $ | +54,9 % | 1 | ||||
| Oric Pharmaceuticals, Inc. | ORIC | → 0 | Neutral | 6.634.253 $ | +1.597.663 $ | +31,7 % | 1 | ||||
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 6.422.120 $ | -146.391 $ | -2,2 % | 1 | 6.568.511 $ | +6.568.511 $ | 1 | |
| 179.846.220 $ | +39.780.652 $ | +31,3 % | 14 | 125.413.752 $ | +125.413.752 $ | 11 | |||||